comparemela.com

Latest Breaking News On - Gil blum - Page 8 : comparemela.com

Geron (GERN) Q1 2023 Earnings Call Transcript

GERN earnings call for the period ending March 31, 2023.

United-states
American
John-scarlett
Kalpit-patelb-riley
Stephen-willey
Faye-feller
Corinne-jenkins
Gil-blum
Corinne-jenkins-goldman-sachs
Aaron-feingold
Steven-willey
Kalpit-patel

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2023 Financial Results Conference Call and Operational Progress.

Switzerland
Mizuho
Hokkaido
Japan
Chicago
Illinois
United-states
London
City-of
United-kingdom
Stevenage
Hertfordshire

Sarepta Therapeutics (SRPT) Q1 2023 Earnings Call Transcript

SRPT earnings call for the period ending March 31, 2023.

Maryland
United-states
Kristen-kluska-cantor-fitzgerald
Danielle-brill
Judah-frommer
Doug-ingram
Brian-skorney
Hartaj-singh
Ian-estepan
Anupam-rama
Gena-wang-barclays
Joseph-schwartz

Autolus Therapeutics (AUTL) Receives a Buy from Needham

Needham analyst Gil Blum reiterated a Buy rating on Autolus Therapeutics (AUTL – Research Report) today and set a price target of $7.00. T.

London
City-of
United-kingdom
Gil-blum
Selecta-biosciences
Autolus-therapeutics-plc
Autolus-therapeutics
Research-report
Nurix-therapeutics
Strong-buy
Mizuho-securities
Autolus-therapeutic

Geron (GERN) Q4 2022 Earnings Call Transcript

GERN earnings call for the period ending December 31, 2022.

Kalpit-patel
John-scarlett
Stephen-willey
Faye-feller
Gil-blum-needham
Kalpit-patelb-riley
Aaron-feingold
Joel-beatty
Gil-blum
Steve-willey-stifel-financial-corp
Geron-corporation
Corporate-communications

vimarsana © 2020. All Rights Reserved.